Despus de suspender la semaglutida, el peso promedio individual se reduce en cerca de dos tercios (67%) del peso que se pierde durante el tratamiento al ao siguiente
Common signs of GLP-1-related body skin changes include: Sagging skin on the upper arms, abdomen, inner thighs, and under the chin Crepey texture a thin, tissue-paper-like appearance, most noticeable on the arms, chest, and knees Rough, uneven texture as skin loses hydration and the outer skin barrier weakens Dullness due to reduced circulation, moisture, and cellular turnover Skin laxity skin that feels loose or less supported as fat volume decreases These changes are not permanent or inevitable and with the right approach, you can meaningfully support your skin's ability to adapt, visibly improving firmness, texture, and hydration over time
At IV Drips , were dedicated to providing safe, effective, and personalized NAD therapy
You still benefit from knowing your baseline health before starting a medication that changes metabolic function
"Peptides are definitely not for everybody, and remember, this is not FDA-approved for any indication